PF
ABEO icon

Phoenix Financial’s Abeona Therapeutics ABEO Stock Holding History

Phoenix Financial’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,874
Closed -$33.3K – 311
2023
Q1 		$33.3K Hold
11,874
– – ﹤0.01% 277
2022
Q4 		$33.5K Hold
11,874
– – ﹤0.01% 276
2022
Q3 		$35K Sell
11,874
-1
-0% -$4 ﹤0.01% 332
2022
Q2 		$59K Hold
11,875
– – ﹤0.01% 368
2022
Q1 		$91K Hold
11,875
– – ﹤0.01% 401
2021
Q4 		$85K Hold
11,875
– – ﹤0.01% 376
2021
Q3 		$326K Sell
11,875
-125
-1% -$4K 0.01% 354
2021
Q2 		$491K Buy
+12,000
New +$490K 0.01% 273

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Phoenix Financial's ABEO Position: Q2 2023 in Review

Phoenix Financial sold out of Abeona Therapeutics (ABEO) in Q2 2023, closing a stake of 11,874 shares — an estimated $33.3K sold.

Phoenix Financial first reported a position in ABEO in Q2 2021 and held it in 8 quarters. The position peaked at $491K in Q2 2021. 37 funds tracked by Wall St. Rank hold ABEO as of Q2 2023.

  • Phoenix Financial reported no remaining Abeona Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Phoenix Financial sold 11,874 Abeona Therapeutics shares in Q2 2023, an estimated $33.3K.
  • Phoenix Financial first reported a position in Abeona Therapeutics in Q2 2021 and held it in 8 quarters.
  • Phoenix Financial's Abeona Therapeutics position peaked at $491K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2023.

Based on Phoenix Financial's 13F filing for Q2 2023, filed 7 Aug 2023.